- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/54 - Interleukins [IL]
Patent holdings for IPC class C07K 14/54
Total number of patents in this class: 3785
10-year publication summary
|
143
|
191
|
254
|
288
|
393
|
430
|
402
|
459
|
434
|
177
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1152 |
124 |
| Regeneron Pharmaceuticals, Inc. | 4223 |
77 |
| Xencor, Inc. | 396 |
61 |
| Altor BioScience, LLC | 74 |
56 |
| Immunitybio, Inc. | 371 |
47 |
| Board of Regents, The University of Texas System | 5751 |
41 |
| The Board of Trustees of the Leland Stanford Junior University | 6365 |
40 |
| Modernatx, Inc. | 1260 |
37 |
| The Trustees of the University of Pennsylvania | 4308 |
36 |
| Obsidian Therapeutics, Inc. | 81 |
33 |
| Genentech, Inc. | 3961 |
31 |
| Yale University | 2358 |
31 |
| City of Hope | 979 |
30 |
| Memorial Sloan-Kettering Cancer Center | 1910 |
29 |
| National University of Singapore | 2428 |
29 |
| Deka Biosciences, Inc. | 43 |
29 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2837 |
28 |
| Cytune Pharma | 39 |
25 |
| The Regents of the University of California | 19812 |
24 |
| Philogen S.p.A. | 124 |
23 |
| Other owners | 2954 |